Cargando…
Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708494/ https://www.ncbi.nlm.nih.gov/pubmed/36467370 http://dx.doi.org/10.21037/atm-22-4581 |
| _version_ | 1784840946979962880 |
|---|---|
| author | Stenvang, Jan Vestlev, Peter Michael Jensen, Benny Vittrup Pfeiffer, Per |
| author_facet | Stenvang, Jan Vestlev, Peter Michael Jensen, Benny Vittrup Pfeiffer, Per |
| author_sort | Stenvang, Jan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9708494 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97084942022-12-01 Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer Stenvang, Jan Vestlev, Peter Michael Jensen, Benny Vittrup Pfeiffer, Per Ann Transl Med Editorial Commentary AME Publishing Company 2022-11 /pmc/articles/PMC9708494/ /pubmed/36467370 http://dx.doi.org/10.21037/atm-22-4581 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Stenvang, Jan Vestlev, Peter Michael Jensen, Benny Vittrup Pfeiffer, Per Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer |
| title | Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer |
| title_full | Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer |
| title_fullStr | Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer |
| title_full_unstemmed | Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer |
| title_short | Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer |
| title_sort | antibody-drug conjugates (adcs) targeting trophoblast cell surface antigen 2 (trop-2) and precision treatment of breast cancer |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708494/ https://www.ncbi.nlm.nih.gov/pubmed/36467370 http://dx.doi.org/10.21037/atm-22-4581 |
| work_keys_str_mv | AT stenvangjan antibodydrugconjugatesadcstargetingtrophoblastcellsurfaceantigen2trop2andprecisiontreatmentofbreastcancer AT vestlevpetermichael antibodydrugconjugatesadcstargetingtrophoblastcellsurfaceantigen2trop2andprecisiontreatmentofbreastcancer AT jensenbennyvittrup antibodydrugconjugatesadcstargetingtrophoblastcellsurfaceantigen2trop2andprecisiontreatmentofbreastcancer AT pfeifferper antibodydrugconjugatesadcstargetingtrophoblastcellsurfaceantigen2trop2andprecisiontreatmentofbreastcancer |